Year: 2016
Language: English
Author(s): Rebecca Kruse-Jarres
In the Monday afternoon session on alternative therapies in the management of inhibitors, Rebecca Kruse-Jarres discusses the latest developments in the use of porcine factor VIII.
In these sessions from the WFH 2022 World Congress, David Lillicrap, Len Valentino, Sophie Susen, Mrinal Gounder, Rebecca Kruse-Jarres, Christine
Also Available In: English, Spanish This is not an official WFH translation. This resource has been translated with permission by
The development of inhibitory antibodies to therapeutic factor VIII (FVIII) in up to 40% of people with severe hemophilia A
In the Monday morning session entitled Inhibitors: Clinical Aspects, Jan Astermark described the different diagnostic assays laboratories can carry out
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Traditional Chinese Inhibitors
In the Monday afternoon session on innovating immune tolerance induction for hemophilia, Shannon Meeks explains the mechanisms of inhibitors.